Long-term follow-up of rituximab in treatment of chronic graft-versus-host disease-single center experience

Annals of Hematology
Sebastian KlobuchDaniel Wolff

Abstract

Rituximab was recently described also as first-line therapy of chronic graft-versus-host disease (cGvHD). We retrospectively analyzed the efficacy and safety of all patients receiving rituximab for treatment of cGvHD between 2005 and 2016 at the Regensburg University transplant center with a median follow-up after rituximab therapy of 2.8 years. Responses of 29 allogeneic stem cell-transplanted patients (median age 49) with previous failure of response to steroids including one patient after donor lymphocyte infusion were assessed. Three months after rituximab application, the overall response rate was 31% (7% complete (n = 2) and 24% partial remission (n = 7)). At 12 months, overall survival was 72% (n = 21) and failure-free survival was 24% (n = 7). We further analyzed associations of rituximab response with clinical characteristics showing a higher response rate in steroid-dependent cGvHD patients (89% of 9 responding compared to steroid refractory patients (11% responding)). However, this difference was not statistically significant. Seven patients (24%) (including four lethal infectious complications) developed serious infections requiring hospitalization within 1-9 months after rituximab therapy exclusively in patients fa...Continue Reading

References

Mar 23, 2006·Blood·Corey CutlerEdwin Alyea
Jun 6, 2007·Bone Marrow Transplantation·F ZajaUNKNOWN GITMO (Gruppo Italiano Trapianto Midollo Osseo)
Feb 19, 2008·Bone Marrow Transplantation·M MohtyD Blaise
Sep 25, 2008·Transplantation·Malte von BoninUwe Platzbecker
Aug 8, 2009·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Mohamed A Kharfan-DabajaAmbuj Kumar
Jul 26, 2011·Bone Marrow Transplantation·L GeorgeP Fernandez-Peñas
Oct 23, 2012·Bone Marrow Transplantation·A ClavertM Mohty
Jun 11, 2014·Blood·Gérard Socié, Jerome Ritz
Oct 2, 2014·The Journal of Clinical Investigation·Jason A DubovskyBruce R Blazar
Feb 4, 2015·Blood·Stefanie Sarantopoulos, Jerome Ritz
May 20, 2015·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Scott R SolomonAsad Bashey
Sep 18, 2015·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Sally AraiMary E D Flowers
Apr 19, 2016·Bone Marrow Transplantation·M A GillissenM D Hazenberg
Dec 28, 2017·The New England Journal of Medicine·Robert Zeiser, Bruce R Blazar
Jun 7, 2018·Bone Marrow Transplantation·Helene M SchoemansUNKNOWN EBMT (European Society for Blood and Marrow Transplantation) Transplant Complications Working Party and the “EBMT−NIH (Natio

❮ Previous
Next ❯

Citations

May 23, 2020·Pharmacotherapy·Rebecca M Gonzalez, Joseph Pidala
Jan 31, 2021·Annals of Hematology·Tobias WertheimerDaniel Wolff

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.